TSHA (Taysha Corp) Net earnings per share change in current year

Official company branding of tayshagtx.com (TSHA)

Taysha Gene Therapies (TSHA) is optimizing expenses by outsourcing clinical trials to third-party contractors. The YoY EPS percentage shift demonstrates the correlation between market price and financial dynamics, with the indicator settling at -30.60. Growth for the company is driven by the success of the TSHA-102 drug for Rett syndrome and its orphan drug status. High margins and unique gene delivery systems facilitate the global scaling of the business.

Earnings per share growth in current year: Taysha Corp (TSHA) for 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Taysha Gene Therapies, Inc. (TSHA)

- stock price and consensus target price:
Summary company analysis:Taysha - TSHA
Signature product of tayshagtx.com

The development of Taysha Gene Therapies (TSHA) relies on clinical success in treating rare pathologies, rendering the business independent of macroeconomic cycles. By analyzing the annual trend of net income per share, an investor assesses the percentage change in EPS compared to last year, filtering out market noise to identify real growth, which confirms the fundamental stability of the quotes regardless of speculative fluctuations.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|QURE: Earnings growth in current year|MGTX - Expected net earnings per share growth this year|Net earnings per share growth this year RGNX|SLDB: Earnings per share increase in current year|Earnings per share growth in current year ocugen.com (OCGN)|Expected net earnings per share growth this year PacBio Corp|Earnings per share growth in current year Benitec Biopharma BNTC|DSGN: Earnings per share growth this year|RCKT - Earnings per share growth in current year|4dmoleculartherapeutics.com (FDMT) - Net earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Korro Bio, Inc (KRRO) - Earnings growth in current year|EDIT (editasmedicine.com) - Earnings growth in current year|Earnings per share growth this year SLN (silence-therapeutics.com)|Earnings per share growth in current year proqr.com (PRQR)|Codexis - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics)|Earnings growth in current year nautilus.bio NAUT|Metagenomi Inc. - Earnings growth in current year|DTIL (Precision BioSciences Inc.) - Earnings per share growth this year|GBIO: Earnings growth in current year|Earnings per share growth rate in current year Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Earnings growth in current year|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year